Patents by Inventor Qinglin DU

Qinglin DU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL CONJUGATE MOLECULES TARGETING CD39 AND TGFBETA
    Publication number: 20230416394
    Abstract: Provided are conjugate molecules comprising a CD39 inhibitory portion capable of interfering interaction between CD39 and its substrate, and a TGF ? inhibitory portion capable of interfering interaction between TGF ? and its receptor, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof.
    Type: Application
    Filed: November 25, 2021
    Publication date: December 28, 2023
    Inventors: Dawei SUN, Zhihao WU, Jun SUN, Yanan GENG, Rui GAO, Lili TANG, Qinglin DU, Yangsheng QIU, Robert H. ARCH, Hongtao LU
  • NOVEL ANTI-CD39 ANTIBODIES
    Publication number: 20210388105
    Abstract: Provided are anti-CD39 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof.
    Type: Application
    Filed: August 26, 2020
    Publication date: December 16, 2021
    Inventors: Yangsheng QIU, Meiling SUN, Roumei XING, Dan XU, Yufei SHI, Jinfeng ZHAO, Qinglin DU, Zhihao WU, Rui GAO, Robert H. ARCH, Hongtao LU
  • NOVEL ANTI-SIRPA ANTIBODIES
    Publication number: 20210347908
    Abstract: Provided are anti-SIRP? antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof.
    Type: Application
    Filed: August 18, 2020
    Publication date: November 11, 2021
    Inventors: Xiaofeng NIU, Jingfeng YU, Jinfeng ZHAO, Fengli WANG, Dan XU, Roumei XING, Zhihao WU, Qinglin DU, Yangsheng QIU, Robert H. ARCH, Hongtao LU